by Rachel Bisiewicz, BS; Obi Okafor, PhD | August 1, 2018
Oncology has developed into the biggest therapy class in terms of revenues for the pharmaceutical industry.1 A better understanding of cancer cell mechanisms, innovative biologic drugs
Read More
by Maria Filsinger Interrante, BS | July 12, 2018
The advent of antibiotic therapy was one of the most impactful medical innovations of the 20th century. However, as resistance has waxed and antibiotic development has waned, multidrug-resistant bacterial
by Qi Fu, PhD | July 12, 2018
DNA encoded chemical libraries (DECLs) is an emerging technology used for high-throughput screening (HTS). DECL technology is rapidly advancing, and a large market exists
by Jennie Yoo, BS | July 12, 2018
While the AD biomarker diagnostic market currently faces many barriers to clinical adoption due to lack of insurance testing coverage and biomarkers based on anti-amyloid hypothesis
by Courtney Gegg, MS | July 12, 2018
Using CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) to genetically engineer hematopoietic stem cells (HSCs) for therapeutic applications is an emerging market that holds promise
